Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Phesgo, Polivy, and Tecentriq; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept, an immunosuppressant; Enspryng, a pH-dependent binding humanized anti-IL-6 recept...
Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 3 3281 6611
Fax: 81 3 3281 2828
Address:
Nihonbashi Mitsui Tower, Reception12F 1-1 Nihonbashi-Muromachi 2-chome, Chuo, Japan
